E
EchoPixel
EchoPixel develops medical imaging devices that enable doctors to use CT images of a patient’s abdomen and display a 3D model
About EchoPixel
EchoPixel is a pioneering company in the healthcare technology sector, specializing in the development of advanced mixed reality software for surgical planning. The company's flagship product, True 3D, transforms traditional 2D medical imaging into an intuitive, interactive 3D environment, allowing clinicians to view and interact with patient-specific anatomy in a more precise and personalized manner. This innovative approach aims to improve diagnosis and optimize surgical outcomes by providing a clearer and more comprehensive understanding of anatomical structures. EchoPixel primarily serves healthcare institutions, including leading hospitals and medical centers, which are looking to enhance their surgical planning capabilities. The company operates in the medical imaging and surgical planning market, leveraging a business model that includes software licensing and service agreements. Revenue is generated through the sale of software licenses, maintenance contracts, and professional services. EchoPixel's technology is FDA-cleared and compliant with PACS and DICOM standards, ensuring seamless integration with existing medical imaging systems. The company's commitment to transforming patient care through disruptive technology has positioned it as a leader in the field of surgical imaging and planning.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- San Jose, United States
- Employees
- 16
- Open positions
- None listed
- Dealroom signal
- 76.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Core AI, Immersive Technologies, Hard Tech
- Technology
- Artificial Intelligence, 3D Technology, Big Data, Deep Tech, Virtual Reality, Computer Vision
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| OtherOther financing | Jun 2023 | $0 | — | MedTech Innovator | ↗ |
| SERIES A✓Equity / VC | Oct 2017 | $8.5M | $34M | Harris & Harris Group · Aurus Capital · Intel Capital · Runa Capital | ↗ |
Growth signals
Latest recorded traffic for EchoPixel is 1.5K monthly website visits, down 34.8% over the last three months. EchoPixel's team grew 14.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Harris & Harris Group
Aurus
Series A5 investors entered at this stage
Larnabel Ventures
Intel Capital- ACAurus Capital
Runa Capital
Binomial Ventures
Series B and later1 investor entered at this stage
Aurus Technologies
Other known investors6 additional known investors
MedTech Innovator
Intel Corporation- KSKYTO Technology & Life Science
- LCLam Capital
Lam Research
Oleg Koujikov
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about EchoPixel on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EchoPixel’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.